| Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers JL Bayart, J Douxfils, C Gillot, C David, F Mullier, M Elsen, C Eucher, ... Vaccines 9 (10), 1092, 2021 | 116 | 2021 |
| Head-to-head comparison of rapid and automated antigen detection tests for the diagnosis of SARS-CoV-2 infection J Favresse, C Gillot, M Oliveira, J Cadrobbi, M Elsen, C Eucher, ... Journal of clinical medicine 10 (2), 265, 2021 | 90 | 2021 |
| Neutralizing antibodies in COVID-19 patients and vaccine recipients after two doses of BNT162b2 J Favresse, C Gillot, L Di Chiaro, C Eucher, M Elsen, S Van Eeckhoudt, ... Viruses 13 (7), 1364, 2021 | 85 | 2021 |
| Persistence of anti-SARS-CoV-2 antibodies depends on the analytical kit: a report for up to 10 months after infection J Favresse, C Eucher, M Elsen, C Gillot, S Van Eeckhoudt, JM Dogné, ... Microorganisms 9 (3), 556, 2021 | 59 | 2021 |
| Analytical sensitivity of six SARS-CoV-2 rapid antigen tests for omicron versus delta variant JL Bayart, J Degosserie, J Favresse, C Gillot, M Didembourg, HP Djokoto, ... Viruses 14 (4), 654, 2022 | 54 | 2022 |
| NETosis and the immune system in COVID-19: mechanisms and potential treatments C Gillot, J Favresse, F Mullier, T Lecompte, JM Dogne, J Douxfils Frontiers in pharmacology 12, 708302, 2021 | 53 | 2021 |
| An original ELISA-based multiplex method for the simultaneous detection of 5 SARS-CoV-2 IgG antibodies directed against different antigens C Gillot, J Douxfils, J Cadrobbi, K Laffineur, JM Dogné, M Elsen, C Eucher, ... Journal of clinical medicine 9 (11), 3752, 2020 | 38 | 2020 |
| Vaccine‐induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster J Favresse, C Gillot, JL Bayart, C David, G Simon, L Wauthier, M Closset, ... Journal of medical virology 95 (1), e28164, 2023 | 23 | 2023 |
| Post-SARS-CoV-2 vaccination specific antibody decrease—Thresholds for determining seroprevalence and seroneutralization differ J Douxfils, C Gillot, F Mullier, J Favresse Journal of Infection 83 (4), e4-e5, 2021 | 21 | 2021 |
| Serum SARS-CoV-2 antigens for the determination of COVID-19 severity J Favresse, JL Bayart, C David, C Gillot, G Wieërs, G Roussel, G Sondag, ... Viruses 14 (8), 1653, 2022 | 16 | 2022 |
| Long-term kinetics of anti-SARS-CoV-2 antibodies in a cohort of 197 hospitalized and non-hospitalized COVID-19 patients J Favresse, M Elsen, C Eucher, K Laffineur, S Van Eeckhoudt, JB Nicolas, ... Clinical Chemistry and Laboratory Medicine (CCLM) 59 (5), e179-e183, 2021 | 16 | 2021 |
| NETosis and nucleosome biomarkers in septic shock and critical COVID-19 patients: an observational study L Morimont, M Dechamps, C David, C Bouvy, C Gillot, H Haguet, ... Biomolecules 12 (8), 1038, 2022 | 14 | 2022 |
| Dynamics of neutralizing antibody responses following natural SARS-CoV-2 infection and correlation with commercial serologic tests. a reappraisal and indirect comparison with … C Gillot, J Favresse, V Maloteau, JM Dogné, J Douxfils Viruses 13 (11), 2329, 2021 | 11 | 2021 |
| Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals JL Bayart, C Gillot, JM Dogné, G Roussel, V Verbelen, J Favresse, ... Journal of Clinical Virology 161, 105419, 2023 | 9 | 2023 |
| Efficient maternal to neonate transfer of neutralizing antibodies after SARS-CoV-2 vaccination with BNT162b2: a case-report and discussion of the literature J Douxfils, C Gillot, É De Gottal, S Vandervinne, JL Bayart, JM Dogné, ... Vaccines 9 (8), 907, 2021 | 9 | 2021 |
| Waning of IgG, total and neutralizing antibodies 6 months post-vaccination with BNT162b2 in healthcare workers. Vaccines (Basel) 2021; 9: 1092 JL Bayart, J Douxfils, C Gillot, C David, F Mullier, M Elsen, C Eucher, ... PUBMED, 0 | 9 | |
| Identification of SARS-CoV-2 neutralizing antibody with pseudotyped virus-based test on HEK-293T hACE2 cells C Gillot, J Favresse, V Maloteau, JM Dogné, J Douxfils Bio-protocol 12 (7), e4377-e4377, 2022 | 7 | 2022 |
| Neutralizing antibodies in COVID-19 patients and vaccine recipients after two doses of BNT162b2. Viruses 2021; 13: 1364 J Favresse, C Gillot, L Di Chiaro, C Eucher, M Elsen, S Van Eeckhoudt, ... Publisher’s Note Springer Nature remains neutral with regard to …, 2021 | 7 | 2021 |
| Lung transplant recipients immunogenicity after heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA vaccination E Catry, J Favresse, C Gillot, JL Bayart, D Frérotte, M Dumonceaux, ... Viruses 14 (7), 1470, 2022 | 6 | 2022 |
| Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment J Favresse, JL Bayart, C David, M Didembourg, C Gillot, JM Dogné, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (5), e97-e100, 2022 | 6 | 2022 |
Jonathan DouxfilsAcademic at the University of NamurAdresse e-mail validée de unamur.be
